2023
DOI: 10.1016/j.cmi.2023.04.030
|View full text |Cite
|
Sign up to set email alerts
|

Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 65 publications
0
0
0
Order By: Relevance
“…Reliance on IV therapy for bacteremia and even endocarditis has also been challenged, with trials and large retrospective studies available to support similar efficacy outcomes in selected patients, with shorter hospitalization and fewer adverse events. 8 It should be noted that this evidence is emerging from studies undertaken in adults, with limited pediatric data published to date.…”
Section: Pediatric Bacteremia and Meningitismentioning
confidence: 99%
“…Reliance on IV therapy for bacteremia and even endocarditis has also been challenged, with trials and large retrospective studies available to support similar efficacy outcomes in selected patients, with shorter hospitalization and fewer adverse events. 8 It should be noted that this evidence is emerging from studies undertaken in adults, with limited pediatric data published to date.…”
Section: Pediatric Bacteremia and Meningitismentioning
confidence: 99%
“…Despite recent advances, the IE outcome remains poor. More research is needed, particularly in uncommon subgroups such as children [14,15], pulmonary IE [16], multivalvular IE [17], patients with solid organ transplantation [18,19], bicuspid aortic valves [20], and those treated with oral therapy [21]. In addition, better prognostic markers [22,23], more specific imaging techniques [24], and improved surgical scores [25] that aid in clinical decision-making are required.…”
mentioning
confidence: 99%